処方整形外科用医薬品の世界市場レポート 2025年

処方整形外科用医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で653億2,000万米ドルに成長します。予測期間における成長の原動力は、生物学的製剤に対する需要の高まり、高齢者人口の増加、新興市場におけるヘルスケアアクセスの拡大、慢性筋骨格系疾患の有病率の増加、整形外科用医薬品の研究開発に対する投資の増加であると予想されます。主な動向としては、標的生物製剤の進歩、再生医療療法の採用、個別化された薬剤製剤、低侵襲デリバリー法の革新、遺伝子治療による薬効増強、注射剤製剤の発展、薬剤開発と臨床意思決定における人工知能の統合などが挙げられます。

筋骨格系障害の有病率の増加は、処方整形外科用医薬品市場の拡大を促進すると予想されます。筋骨格系障害（MSD）には、筋肉、腱、靭帯、神経、関節を含む身体の筋骨格系の動きや機能に影響を与え、痛みや運動制限につながる傷害や状態が含まれます。これらの障害の発生が増加しているのは、加齢、反復運動やぎこちない姿勢を伴う職業活動、座りっぱなしのライフスタイル、不十分な栄養、遺伝的素因などの要因によるものです。処方整形外科用医薬品は、疼痛を緩和し、炎症を抑え、治癒プロセスを促進することで、最終的に可動性と全体的な生活の質を向上させ、筋骨格系障害の管理において重要な役割を果たします。例えば、2023年3月、英国政府の公衆衛生部門であるOffice for Health Improvement and Disparitiesは、2022年における16歳以上の個人の17.6％が、関節炎や持続的な背中や関節の問題のような長期の筋骨格系（MSK）疾患を有しており、2021年の17.0％から増加していると報告しました。さらに、2022年7月、スイスに本部を置く政府間機関である世界保健機関は、世界で約17億1,000万人が筋骨格系障害に苦しんでいると推定しました。その結果、筋骨格系障害の有病率の増加が処方整形外科用医薬品市場の成長に拍車をかけています。

アンメットキーワード分野の主要企業は、市場参入の拡大、患者の転帰の改善、さまざまな整形外科疾患におけるアンメット・メディカル・ニーズへの対応などを目的として、自社医薬品の適応拡大を優先しています。例えば、2023年1月、米国のバイオテクノロジー企業であるHeron Therapeutics Inc.は、足や足首の手術を含む軟部組織および整形外科手術におけるZYNRELEF（ブピバカインおよびメロキシカム）の使用拡大についてFDAの承認を取得しました。この徐放性製剤は、最大72時間まで鎮痛効果を持続させ、術後のオピオイド投薬の必要性を最小化または排除するよう特別に設計されています。適応症の拡大により、整形外科手術や軟部組織手術の範囲が広がり、臨床現場での使用範囲が拡大しました。この薬剤の革新的な2剤併用は、局所麻酔作用と抗炎症作用の両方を発揮し、患者の予後を改善しながら術後疼痛を管理する包括的なソリューションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界処方整形外科用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の処方整形外科用医薬品市場：成長率分析
• 世界の処方整形外科用医薬品市場の実績：規模と成長, 2019-2024
• 世界の処方整形外科用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界処方整形外科用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の処方整形外科用医薬品市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• コルチコステロイド
• 疾患修飾抗リウマチ薬（DMARD）
• その他の薬物の種類
• 世界の処方整形外科用医薬品市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 変形性関節症
• 関節リウマチ
• 骨粗鬆症
• その他の用途
• 世界の処方整形外科用医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界の処方整形外科用医薬品市場非ステロイド性抗炎症薬（NSAIDs）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• イブプロフェン
• ナプロキセン
• ジクロフェナク
• セレコキシブ
• インドメタシン
• 世界の処方整形外科用医薬品市場オピオイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モルヒネ
• オキシコドン
• ヒドロコドン
• フェンタニル
• トラマドール
• 世界の処方整形外科用医薬品市場コルチコステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレドニゾン
• メチルプレドニゾロン
• デキサメタゾン
• ヒドロコルチゾン
• ベタメタゾン
• 世界の処方整形外科用医薬品市場疾患修飾性抗リウマチ薬（DMARD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトトレキサート
• ヒドロキシクロロキン
• レフルノミド
• スルファサラジン
• アザチオプリン
• 世界の処方整形外科用医薬品市場、その他の薬剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビスホスホネート
• カルシトニン
• モノクローナル抗体
• 筋弛緩剤
• ヒアルロン酸注射

第7章 地域別・国別分析

• 世界の処方整形外科用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の処方整形外科用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 処方整形外科用医薬品市場：競合情勢
• 処方整形外科用医薬品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• GSK Plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Biogen Inc.
• UCB S.A.
• Allergan plc
• Penardo Biotech Pvt. Ltd.
• Horizon Therapeutics plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 処方整形外科用医薬品市場2029：新たな機会を提供する国
• 処方整形外科用医薬品市場2029：新たな機会を提供するセグメント
• 処方整形外科用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prescription orthopedic drugs are medications specifically prescribed to treat musculoskeletal conditions affecting bones, joints, muscles, and ligaments. These drugs help relieve pain, reduce inflammation, and promote healing in orthopedic injuries and disorders such as arthritis, fractures, and tendonitis.

The primary types of prescription orthopedic drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and others. NSAIDs are a class of medications that alleviate pain, inflammation, and fever by inhibiting enzymes responsible for prostaglandin production. These drugs are commonly used to manage conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The prescription orthopedic drugs market research report is one of a series of new reports from The Business Research Company that provides prescription orthopedic drugs market statistics, including the prescription orthopedic drugs industry's global market size, regional shares, competitors with a prescription orthopedic drugs market share, detailed prescription orthopedic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription orthopedic drugs industry. This prescription orthopedic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prescription orthopedic drugs market size has grown strongly in recent years. It will grow from $48.41 billion in 2024 to $51.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period was driven by the rising prevalence of musculoskeletal disorders, an increasing geriatric population, greater awareness of osteoporosis treatments, expanded healthcare access in developing regions, and a surge in sports-related injuries worldwide.

The prescription orthopedic drugs market size is expected to see strong growth in the next few years. It will grow to $65.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period is expected to be driven by the rising demand for biologics, an increasing geriatric population, expanded healthcare access in emerging markets, a growing prevalence of chronic musculoskeletal disorders, and increased investments in orthopedic drug research and development. Key trends include advancements in targeted biologics, the adoption of regenerative medicine therapies, personalized drug formulations, innovations in minimally invasive delivery methods, enhanced drug efficacy through gene therapy, developments in injectable formulations, and the integration of artificial intelligence in drug development and clinical decision-making.

The growing prevalence of musculoskeletal disorders is expected to propel the expansion of the prescription orthopedic drugs market. Musculoskeletal disorders (MSDs) encompass injuries and conditions that impact the movement and function of the body's musculoskeletal system, including muscles, tendons, ligaments, nerves, and joints, leading to pain and restricted mobility. The rising occurrence of these disorders can be attributed to factors such as aging, occupational activities involving repetitive motions and awkward postures, sedentary lifestyles, inadequate nutrition, and genetic predispositions. Prescription orthopedic drugs play a crucial role in managing musculoskeletal disorders by alleviating pain, reducing inflammation, and promoting the healing process, ultimately improving mobility and overall quality of life. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department for public health, reported that 17.6% of individuals aged 16 and older in 2022 had a long-term musculoskeletal (MSK) condition, such as arthritis or persistent back or joint problems, an increase from 17.0% in 2021. Additionally, in July 2022, the World Health Organization, a Switzerland-based intergovernmental organization, estimated that approximately 1.71 billion people worldwide suffer from musculoskeletal disorders. As a result, the increasing prevalence of musculoskeletal disorders is fueling the growth of the prescription orthopedic drugs market.

Leading companies in the prescription orthopedic drugs sector are prioritizing the expansion of indications for their drugs to extend market reach, enhance patient outcomes, and address unmet medical needs across various orthopedic conditions. For instance, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, received FDA approval for the extended use of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, including foot and ankle surgeries. This extended-release formulation is specifically designed to provide prolonged pain relief for up to 72 hours, minimizing or eliminating the need for opioid medications post-surgery. The expanded indication now encompasses a wider range of orthopedic and soft tissue procedures, broadening its use in clinical settings. The drug's innovative dual-drug combination delivers both local anesthetic and anti-inflammatory effects, offering a comprehensive solution for managing post-operative pain while improving patient outcomes.

In April 2024, ProMed Pharma LLC, a US-based pharmaceutical company, acquired SpineThera Inc. for an undisclosed sum. Through this acquisition, ProMed aims to strengthen its drug delivery capabilities by utilizing SpineThera's expertise in extended-release injectable therapies, particularly in pain management for musculoskeletal and orthopedic conditions. SpineThera Inc. is a US-based company specializing in the development of extended-release injectable therapies for treating musculoskeletal conditions, including back pain and orthopedic disorders.

Major players in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc.

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in prescription orthopedic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prescription orthopedic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prescription orthopedic drugs market consists of sales of products such as bisphosphonates, creams, gels, or patches, calcium and vitamin D supplements, and analgesics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prescription Orthopedic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prescription orthopedic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prescription orthopedic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription orthopedic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Corticosteroids; Disease-Modifying Antirheumatic Drugs (DMARDs); Other Drug Types
• 2) By Application: Osteoarthritis; Rheumatoid Arthritis; Osteoporosis; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Diclofenac; Celecoxib; Indomethacin
• 2) By Opioids: Morphine; Oxycodone; Hydrocodone; Fentanyl; Tramadol
• 3) By Corticosteroids: Prednisone; Methylprednisolone; Dexamethasone; Hydrocortisone; Betamethasone
• 4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate; Hydroxychloroquine; Leflunomide; Sulfasalazine; Azathioprine
• 5) By Other Drug Types: Bisphosphonates; Calcitonin; Monoclonal Antibodies; Muscle Relaxants; Hyaluronic Acid Injections
• Companies Mentioned:Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck KGaA; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prescription Orthopedic Drugs Market Characteristics

3. Prescription Orthopedic Drugs Market Trends And Strategies

4. Prescription Orthopedic Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Prescription Orthopedic Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prescription Orthopedic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prescription Orthopedic Drugs Market Growth Rate Analysis
• 5.4. Global Prescription Orthopedic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prescription Orthopedic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prescription Orthopedic Drugs Total Addressable Market (TAM)

6. Prescription Orthopedic Drugs Market Segmentation

• 6.1. Global Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Opioids
• Corticosteroids
• Disease-Modifying Antirheumatic Drugs (DMARDs)
• Other Drug Types
• 6.2. Global Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osteoarthritis
• Rheumatoid Arthritis
• Osteoporosis
• Other Applications
• 6.3. Global Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ibuprofen
• Naproxen
• Diclofenac
• Celecoxib
• Indomethacin
• 6.5. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine
• Oxycodone
• Hydrocodone
• Fentanyl
• Tramadol
• 6.6. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prednisone
• Methylprednisolone
• Dexamethasone
• Hydrocortisone
• Betamethasone
• 6.7. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methotrexate
• Hydroxychloroquine
• Leflunomide
• Sulfasalazine
• Azathioprine
• 6.8. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bisphosphonates
• Calcitonin
• Monoclonal Antibodies
• Muscle Relaxants
• Hyaluronic Acid Injections

7. Prescription Orthopedic Drugs Market Regional And Country Analysis

• 7.1. Global Prescription Orthopedic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prescription Orthopedic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prescription Orthopedic Drugs Market

• 8.1. Asia-Pacific Prescription Orthopedic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prescription Orthopedic Drugs Market

• 9.1. China Prescription Orthopedic Drugs Market Overview
• 9.2. China Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prescription Orthopedic Drugs Market

• 10.1. India Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prescription Orthopedic Drugs Market

• 11.1. Japan Prescription Orthopedic Drugs Market Overview
• 11.2. Japan Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prescription Orthopedic Drugs Market

• 12.1. Australia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prescription Orthopedic Drugs Market

• 13.1. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prescription Orthopedic Drugs Market

• 14.1. South Korea Prescription Orthopedic Drugs Market Overview
• 14.2. South Korea Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prescription Orthopedic Drugs Market

• 15.1. Western Europe Prescription Orthopedic Drugs Market Overview
• 15.2. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prescription Orthopedic Drugs Market

• 16.1. UK Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prescription Orthopedic Drugs Market

• 17.1. Germany Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prescription Orthopedic Drugs Market

• 18.1. France Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prescription Orthopedic Drugs Market

• 19.1. Italy Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prescription Orthopedic Drugs Market

• 20.1. Spain Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prescription Orthopedic Drugs Market

• 21.1. Eastern Europe Prescription Orthopedic Drugs Market Overview
• 21.2. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prescription Orthopedic Drugs Market

• 22.1. Russia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prescription Orthopedic Drugs Market

• 23.1. North America Prescription Orthopedic Drugs Market Overview
• 23.2. North America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prescription Orthopedic Drugs Market

• 24.1. USA Prescription Orthopedic Drugs Market Overview
• 24.2. USA Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prescription Orthopedic Drugs Market

• 25.1. Canada Prescription Orthopedic Drugs Market Overview
• 25.2. Canada Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prescription Orthopedic Drugs Market

• 26.1. South America Prescription Orthopedic Drugs Market Overview
• 26.2. South America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prescription Orthopedic Drugs Market

• 27.1. Brazil Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prescription Orthopedic Drugs Market

• 28.1. Middle East Prescription Orthopedic Drugs Market Overview
• 28.2. Middle East Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prescription Orthopedic Drugs Market

• 29.1. Africa Prescription Orthopedic Drugs Market Overview
• 29.2. Africa Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prescription Orthopedic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Prescription Orthopedic Drugs Market Competitive Landscape
• 30.2. Prescription Orthopedic Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Prescription Orthopedic Drugs Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca plc
• 31.5. GSK Plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Mylan N.V.
• 31.11. Biogen Inc.
• 31.12. UCB S.A.
• 31.13. Allergan plc
• 31.14. Penardo Biotech Pvt. Ltd.
• 31.15. Horizon Therapeutics plc

32. Global Prescription Orthopedic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prescription Orthopedic Drugs Market

34. Recent Developments In The Prescription Orthopedic Drugs Market

35. Prescription Orthopedic Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Prescription Orthopedic Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prescription Orthopedic Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prescription Orthopedic Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer